Univest
Univest
  • Markets
  • 3 Pharma Excipients and Food Ingredients Maker, Pharmaceutical Company and Dairy Products Company Stocks With a Strong Future Roadmap: Sudeep Pharma, Ipca Laboratories and Dodla Dairy

    • November 6, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Pharma Excipients and Food Ingredients Maker, Pharmaceutical Company and Dairy Products Company Stocks With a Strong Future Roadmap: Sudeep Pharma, Ipca Laboratories and Dodla Dairy

    Excipient, Pharma and Dairy Stocks with a strong future roadmap: Sudeep Pharma, Ipca Laboratories and Dodla Dairy. Compare price, valuation, return on equity and revenue growth as of 5 November 2026.

    read more
  • 3 Pharma Excipients Maker, Flow Control Products Maker and Technical Textiles Maker Stocks With a Strong Future Roadmap: Sudeep Pharma, Jash Engineering and Garware Technical Fibres

    • November 5, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Pharma Excipients Maker, Flow Control Products Maker and Technical Textiles Maker Stocks With a Strong Future Roadmap: Sudeep Pharma, Jash Engineering and Garware Technical Fibres

    Excipient, Flow Control and Fibre Stocks with a strong future roadmap: Sudeep Pharma, Jash Engineering and Garware Technical Fibres. Compare price, valuation, return on equity and revenue growth as of 4 November 2026.

    read more
  • 3 Pharma Excipients and Food Ingredients Maker, Respiratory Medicines Company and Fluorospecialty Chemicals Group Stocks With a Strong Future Roadmap: Sudeep Pharma, Cipla and SRF

    • October 30, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Pharma Excipients and Food Ingredients Maker, Respiratory Medicines Company and Fluorospecialty Chemicals Group Stocks With a Strong Future Roadmap: Sudeep Pharma, Cipla and SRF

    Excipient, Respiratory Drug and Fluorine Stocks with a strong future roadmap: Sudeep Pharma, Cipla and SRF. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more